Primary record
4H-Cyclopent[f]oxacyclotridecin-4-one, 1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-, [1R-(1R*,2E,6S*,10E,11aS*,13S*,14aR*)]-
- 库存
- 636 克
- 纯度
- 98.6 %
- CAS
- 20350-15-6
化合物标识与属性
- CAS
- 20350-15-6
- PubChem CID
- 5351204
- SMILES
- C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@H](/C=C/C(=O)O1)O)O
- Canonical SMILES
- C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@@H](O)/C=C/C(=O)O1
名称与同义词
- brefeldin A
- Ascotoxin
- Decumbin
- Cyanein
- Nectrolide
- Synergisidin
- Cyanaein
- Lunatin
- Brefeldin A prodrug
- (+)-4-epi-Brefeldin A
- AC1NS04E
- UNII-XG0D35F9K6
- MLS002701937
- MLS002702862
- CCRIS 9386
- SCHEMBL4345242
- CHEMBL1734306
- NSC56310
- NSC89671
- C16H24O4
- MFCD12913297
- NSC 56310
- NSC107456
- NSC244390
- AKOS037649525
- C16-H24-O4
- CID5351204
- CP-0070
- SMR001565520
- 20350-15-6
- J3.554.023G
- B 174987
- (1S,2E,7S,10E,12S,13R,15S)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one
- gamma,4-Dihydroxy-2-(6-hydroxy-1-heptenyl)-4-cyclopentanecrotonic acid lambda-lactone
- (1R,2S,3E,7S,11E,13S,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
- (1S,2E,10E)-1beta,13alpha-Dihydroxy-6beta-methyl-1,6,7,8,9,11abeta,12,13,14,14aalpha-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one
- (1S,2E,6S,10E,11aS,13S,14aR)-1,13-dihydroxy-6-methyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f][1]oxacyclotridecin-4-one
- (1S,6S,11aS,13S,14aR)-1,13-dihydroxy-6-methyl-1H,4H,6H,7H,8H,9H,11aH,12H,13H,14H,14aH-cyclopenta[f]oxacyclotridecan-4-one
- 1,6,7,8,9,11a,12,13,14,14a-Decahydro-1,13-dihydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one
- 4H-Cyclopent[f]oxacyclotridecin-4-one, 1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-, (1R,2E,6S,10E,11aS,13S,14aR)-
- 4H-Cyclopent[f]oxacyclotridecin-4-one, 1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-, [1R-(1R*,2E,6S*,10E,11aS*,13S*,14aR*)]-
- 4H-Cyclopent[f]oxacyclotridecin-4-one, 1,6,7,8,9,11a.beta.,12,13,14,14a.alpha.-decahydro-1.beta.,13.alpha.-dihydroxy-6.beta.-methyl-
- 60132-23-2
- BFA